Welcome
Pharma and Healthcare Insight provides subscribers with analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting on global pharma and healthcare markets. The service includes online access to the very latest analysis and data, a searchable archive, and PDF access to the monthly regional Insight reports.
Published by Business Monitor International, the global market specialists, Pharma and Healthcare Insight is broken down into five regional services: Asia, Western Europe, Emerging Europe, the Middle East & Africa and the Americas.
› To Subscribe and gain full access to content for 12 months, click subscribe now.» To access our 
RSS feed of headlines copy this link to your RSS reader
Industry / Thailand
BMI estimates that over 95% of global pharmaceutical sales are made by private enterprises, and predicts that this figure will increase in the future. State-run drugmakers are an anachronism in the modern capitalist age and are either being privatised or shut down. However, there are still several examples across the world. Thailand's Government Pharmaceutical Organisation (GPO)...
2008-04-29Industry / Mexico
In what could be a significant boost to the self-sufficiency of Mexico's pharmaceutical market, state-owned vaccine maker Laboratorios de Biológicos y Reactivos de México (Birmex)...
2008-04-09Industry / Mexico
In what could be a significant boost to the self-sufficiency of Mexico's pharmaceutical market, state-owned vaccine maker Laboratorios de Biológicos y Reactivos de México (Birmex)...
2008-04-09Industry / United States
Providing a small but welcome boost to the US generic drug market, Wal-Mart has expanded its low-priced prescription drug scheme. The world's largest retailer now offers a 90-day course of generic drug prescriptions for US$10, packs of brand-name over-the-counter (OTC) medicines for US$4, and has expanded its offerings of women's health products. As a result, consumers on low...
2008-05-08Industry / India
It is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's...
2008-05-08Industry / Pakistan
Due to erosion of margins, pharmaceutical companies have called on Pakistan's government to allow them to increase the price of medicines. The firms say that the price of drugs has...
2008-05-07Industry
According to a recent report from the World Health Organization, the incidence of tuberculosis (TB) and drug resistant TB (MDR-TB) has risen sharply in Europe over the past decade. However, Central and Eastern Europe (CEE) has been hit disproportionately due to under-funded health
2008-03-28Industry
According to a recent report from the World Health Organization, the incidence of tuberculosis (TB) and drug resistant TB (MDR-TB) has risen sharply in Europe over the past decade....
2008-03-28Industry
According to a recent report from the World Health Organization, the incidence of tuberculosis (TB) and drug resistant TB (MDR-TB) has risen sharply in Europe over the past decade....
2008-03-28Industry / Namibia
Namibia's recently announced 2008/2009 budget has split public opinion. Prominent lobby groups within Namibia, including the Legal Assistance Centre (LAC), have criticised the low priority given the healthcare. Just 9.5% of the budget will be spent on health - well below the 15% target set by African health ministers in April 2007 However, local opposition parties and external...
2008-03-26Companies / Kuwait
Hikma's 2007 performance is being hailed as a success by industry observers. The company's full-year results for 2007 revealed that sales were up by a massive 41.6% on 2006, to US$448mn,...
2008-03-20Companies / Kuwait
Hikma's 2007 performance is being hailed as a success by industry observers. The company's full-year results for 2007 revealed that sales were up by a massive 41.6% on 2006, to US$448mn,...
2008-03-20Industry / Spain
AstraZeneca has announced that it will cut 132 jobs at its Spanish operations as part of a global restructuring programme. The company is planning to cut up to 7,600 jobs worldwide by 2010. AstraZeneca has had a number of set-backs over the past few years, with a lack of new products in the pipeline for the short
2008-04-08Industry / Spain
AstraZeneca has announced that it will cut 132 jobs at its Spanish operations as part of a global restructuring programme. The company is planning to cut up to 7,600 jobs worldwide...
2008-04-08Industry / Spain
AstraZeneca has announced that it will cut 132 jobs at its Spanish operations as part of a global restructuring programme. The company is planning to cut up to 7,600 jobs worldwide...
2008-04-08
